Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: a randomized, three-way crossover study
Authors:
- Domínguez‐ MuñozDMDomínguez‐ Muñoz
- J. E.JEJ. E.
- J. Iglesias‐GarcíaJIJ. Iglesias‐García
- M. Iglesias‐ReyMIM. Iglesias‐Rey
- A. FigueirasAFA. Figueiras
- M. Vilariño‐InsuaMVM. Vilariño‐Insua
- 1 April 2005
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (8) , 993-1000
Abstract
Oral pancreatic enzyme supplements should be properly administered in order to ensure an adequate gastric mixing with the food and simultaneous gastric emptying with the chyme. To evaluate, in a prospective, randomized, open, comparative, three-way, crossover study, the effect of the administration schedule on the efficacy of oral pancreatic enzymes for the treatment of exocrine pancreatic insufficiency. Twenty-four consecutive chronic pancreatitis patients with maldigestion secondary to exocrine pancreatic insufficiency were treated with 40 000 U lipase in the form of capsules containing enteric-coated mini-microspheres. Capsules were taken just before meals (schedule A), just after meals (schedule B) or distributed along with meals (schedule C) for three consecutive 1-week crossover periods in a randomized order. Fat digestion before and during the three treatment periods was evaluated by an optimized mixed (13)C-triglyceride breath test. Before therapy, the (13)CO(2) recovery in the breath test was 23.8 +/- 15.8% (normal >58.0%). During therapy, the (13)CO(2) recovery tended to be higher when capsules were taken along with meals ((13)CO(2) recovery 61.4 +/- 21.4%) or just after meals ((13)CO(2) recovery 60.6 +/- 21.8%) than when taken just before meals ((13)CO(2) recovery 53.9 +/- 20.3%). The percentage of patients who normalized fat digestion under therapy was 50, 54 and 63% with schedules A, B and C respectively. The efficacy of pancreatic enzyme supplements for the treatment of exocrine pancreatic insufficiency may be optimized by administration during or after meals.Keywords
This publication has 21 references indexed in Scilit:
- Accuracy of the optimized 13c-mixed triglyceride breath test for the diagnosis of steatorrhea in clinical practiceGastroenterology, 2003
- A double‐blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiencyAlimentary Pharmacology & Therapeutics, 1999
- Long-term outcome of necrotizing pancreatitis treated by necrosectomyBritish Journal of Surgery, 1998
- Effect of oral pancreatic enzyme administration on digestive function in healthy subjects: comparison between two enzyme preparationsAlimentary Pharmacology & Therapeutics, 1997
- Near-infrared reflectance analysisEuropean Journal of Gastroenterology & Hepatology, 1994
- Prospective Evaluation of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in Patients with Chronic Abdominal Pain of Suspected Pancreatic OriginEndoscopy, 1993
- Functional Reserve Capacity of the Exocrine PancreasDigestion, 1986
- Pancreatography in chronic pancreatitis: international definitions.Gut, 1984
- Fate of Orally Ingested Enzymes in Pancreatic InsufficiencyNew England Journal of Medicine, 1977
- Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic InsufficiencyNew England Journal of Medicine, 1973